Los Angeles Capital Management LLC Lexicon Pharmaceuticals, Inc. Transaction History

Los Angeles Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$1.31 - $2.69 $2,255 - $4,632	1,722 Added 1.21%	144,269 $268,000
Q1 2022 May 06, 2022	BUY	$1.95 - $3.89 $46,176 - $92,115	23,680 Added 19.92%	142,547 $298,000
Q4 2021 Feb 03, 2022	SELL	$3.81 - $6.16 $1,264 - $2,045	-332 Reduced 0.28%	118,867 $468,000
Q3 2021 Nov 08, 2021	BUY	$3.38 - $5.35 $206,011 - $326,082	60,950 Added 104.64%	119,199 $573,000
Q2 2021 Aug 05, 2021	BUY	$4.12 - $5.87 $239,985 - $341,921	58,249 New	58,249 $267,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $134M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Los Angeles Capital Management LLC with notifications on news.